TY - JOUR
T1 - Cardiovascular, respiratory, and related disorders
T2 - key messages from Disease Control Priorities, 3rd edition
AU - Disease Control Priorities-3 Cardiovascular, Respiratory, and Related Disorders Author Group
AU - Prabhakaran, Dorairaj
AU - Anand, Shuchi
AU - Watkins, David
AU - Gaziano, Thomas
AU - Wu, Yangfeng
AU - Mbanya, Jean Claude
AU - Nugent, Rachel
AU - Suhrcke, Marc
N1 - Copyright © 2018 Elsevier Ltd. All rights reserved.
PY - 2018/3/24
Y1 - 2018/3/24
N2 - Cardiovascular, respiratory, and related disorders (CVRDs) are the leading causes of adult death worldwide, and substantial inequalities in care of patients with CVRDs exist between countries of high income and countries of low and middle income. Based on current trends, the UN Sustainable Development Goal to reduce premature mortality due to CVRDs by a third by 2030 will be challenging for many countries of low and middle income. We did systematic literature reviews of effectiveness and cost-effectiveness to identify priority interventions. We summarise the key findings and present a costed essential package of interventions to reduce risk of and manage CVRDs. On a population level, we recommend tobacco taxation, bans on trans fats, and compulsory reduction of salt in manufactured food products. We suggest primary health services be strengthened through the establishment of locally endorsed guidelines and ensured availability of essential medications. The policy interventions and health service delivery package we suggest could serve as the cornerstone for the management of CVRDs, and afford substantial financial risk protection for vulnerable households. We estimate that full implementation of the essential package would cost an additional US$21 per person in the average low-income country and $24 in the average lower-middle-income country. The essential package we describe could be a starting place for low-income and middle-income countries developing universal health coverage packages. Interventions could be rolled out as disease burden demands and budgets allow. Our outlined interventions provide a pathway for countries attempting to convert the UN Sustainable Development Goal commitments into tangible action.
AB - Cardiovascular, respiratory, and related disorders (CVRDs) are the leading causes of adult death worldwide, and substantial inequalities in care of patients with CVRDs exist between countries of high income and countries of low and middle income. Based on current trends, the UN Sustainable Development Goal to reduce premature mortality due to CVRDs by a third by 2030 will be challenging for many countries of low and middle income. We did systematic literature reviews of effectiveness and cost-effectiveness to identify priority interventions. We summarise the key findings and present a costed essential package of interventions to reduce risk of and manage CVRDs. On a population level, we recommend tobacco taxation, bans on trans fats, and compulsory reduction of salt in manufactured food products. We suggest primary health services be strengthened through the establishment of locally endorsed guidelines and ensured availability of essential medications. The policy interventions and health service delivery package we suggest could serve as the cornerstone for the management of CVRDs, and afford substantial financial risk protection for vulnerable households. We estimate that full implementation of the essential package would cost an additional US$21 per person in the average low-income country and $24 in the average lower-middle-income country. The essential package we describe could be a starting place for low-income and middle-income countries developing universal health coverage packages. Interventions could be rolled out as disease burden demands and budgets allow. Our outlined interventions provide a pathway for countries attempting to convert the UN Sustainable Development Goal commitments into tangible action.
KW - Cardiovascular Diseases/prevention & control
KW - Developing Countries
KW - Health Priorities
KW - Humans
KW - Respiratory Tract Diseases/prevention & control
U2 - 10.1016/S0140-6736(17)32471-6
DO - 10.1016/S0140-6736(17)32471-6
M3 - Article
C2 - 29108723
SN - 0140-6736
VL - 391
SP - 1224
EP - 1236
JO - The Lancet
JF - The Lancet
IS - 10126
ER -